Skip to main content

previous disabled Page of 3
and
  1. Article

    Open Access

    Correction to: A comparative genomic analysis of putative pathogenicity genes in the host-specific sibling species Colletotrichum graminicola and Colletotrichum sublineola

    Following the publication of this article [1], the authors informed us of the following error.

    E. A. S. Buiate, K. V. Xavier, N. Moore, M. F. Torres, M. L. Farman in BMC Genomics (2018)

  2. No Access

    Chapter

    Effective Management of the Tripartite Relationship of Educational Providers, Participants and Employers in Work Based Learning

    Rowe, Moss and Moore provide a comprehensive summary of the tripartite partnership that exists between employers, participants and providers in a work-based postgraduate business programme. The chapter examine...

    L. Rowe, D. Moss, N. Moore in Enhancing Employability in Higher Educatio… (2018)

  3. Article

    Managing pain and fatigue in people with spinal cord injury: a randomized controlled trial feasibility study examining the efficacy of massage therapy

    A randomized controlled trial (RCT).

    J Lovas, Y Tran, J Middleton, R Bartrop, N Moore, A Craig in Spinal Cord (2017)

  4. Article

    Open Access

    A comparative genomic analysis of putative pathogenicity genes in the host-specific sibling species Colletotrichum graminicola and Colletotrichum sublineola

    Colletotrichum graminicola and C. sublineola cause anthracnose leaf and stalk diseases of maize and sorghum, respectively. In spite of their close evolutionary relationship, the two species a...

    E. A. S. Buiate, K. V. Xavier, N. Moore, M. F. Torres, M. L. Farman in BMC Genomics (2017)

  5. Article

    Open Access

    A multinational, drug utilisation study to investigate the use of dexmedetomidine (DEXDOR®) in clinical practice in the EU

    C Garratt, M Weatherall, P Pohjanjousi, R Aantao in Intensive Care Medicine Experimental (2015)

  6. No Access

    Article

    Use of the recommended drug combination for secondary prevention after a first occurrence of acute coronary syndrome in France

    The recommended pharmacotherapy for secondary prevention of acute coronary syndrome (ACS) is long-term treatment with a combination of four therapeutic classes: beta-blockers, antiplatelet agents (including as...

    J. Bezin, A. Pariente, R. Lassalle in European Journal of Clinical Pharmacology (2014)

  7. Article

    Open Access

    Insulin glargine and risk of cancer: a cohort study in the French National Healthcare Insurance Database

    Using the Echantillon Généraliste de Bénéficiaires: random 1/97 permanent sample of the French national healthcare insurance system database (EGB), we investigated whether, as previously suspected, the risk of...

    P. Blin, R. Lassalle, C. Dureau-Pournin, B. Ambrosino, M. A. Bernard in Diabetologia (2012)

  8. Article

    Open Access

    AVAglio: Phase 3 trial of bevacizumab plus temozolomide and radiotherapy in newly diagnosed glioblastoma multiforme

    Despite treatment with the current standard-of-care therapies, patients with newly diagnosed glioblastoma multiforme (GBM) exhibit dismal prognoses. Bevacizumab has demonstrated activity in patients with recur...

    O. L. Chinot, T. de La Motte Rouge, N. Moore, A. Zeaiter, A. Das in Advances in Therapy (2011)

  9. Article

    Open Access

    Bleeding events in bevacizumab-treated cancer patients who received full-dose anticoagulation and remained on study

    Bevacizumab provides clinical benefit in multiple solid tumours, but is associated with some increase in bleeding risk. Thrombotic events necessitating therapeutic anticoagulation (TA) are common in cancer. Th...

    N B Leighl, J Bennouna, J Yi, N Moore, J Hambleton, H Hurwitz in British Journal of Cancer (2011)

  10. Article

    Open Access

    ARRDC3 suppresses breast cancer progression by negatively regulating integrin β4

    Large-scale genetic analyses of human tumor samples have been used to identify novel oncogenes, tumor suppressors and prognostic factors, but the functions and molecular interactions of many individual genes h...

    K M Draheim, H-B Chen, Q Tao, N Moore, M Roche, S Lyle in Oncogene (2010)

  11. No Access

    Article

    Antipsychotic Use and Myocardial Infarction in Demented Patients Treated with cholinesterase Inhibitors

    A. Pariente, Y. Moride, A. Dragomir, S. Perreault, A. Fourrier-Réglat in Drug Safety (2008)

  12. No Access

    Article

    Medicines: To Drive or Not to Drive.. Epilogue

    A. Bénard-Laribière, E. Fort, T. Floresta, N. Fone-Tchoura, A. Pasturaud in Drug Safety (2008)

  13. No Access

    Article

    Cholinesterase Inhibitors in Demented Patients: Impact of Treatment Non-Persistence on Institutionalization or Death

    A. Pariente, Y. Moride, A. Dragomir, S. Perreault, A. Fourrier-Réglaf in Drug Safety (2008)

  14. No Access

    Article

    Case Series in Drug Safety Surveillance: Are they Useful as a Risk Management Tool?

    A. Pariente, M. Pinet, N. Moore, Y. Moride in Drug Safety (2008)

  15. No Access

    Article

    Data Mining on Large Health Record Databases for Detecting Adverse Reactions: Which Events to Monitor?

    G. Trifiro’, A. Pariente, G. Polimeni, G. Miremont-Salame’, M. A. Catania in Drug Safety (2008)

  16. No Access

    Article

    Poster Presentations

    H. Théophile, G. Miremont-Salamé, N. Moore, F. Haramburu in Drug Safety (2007)

  17. No Access

    Article

    Oral Presentations

    A. Pariente, M. Didailler, P. Avillach, G. G. Miremont-Salamé in Drug Safety (2007)

  18. No Access

    Article

    Poster Presentations

    F. Gregoire, A. Pariente, F. Haramburu, N. Moore in Drug Safety (2007)

  19. No Access

    Article

    Oral Presentations

    P. Avillach, A. Pariente, F. Thiessard, G. Miremont-Salamé in Drug Safety (2007)

  20. No Access

    Article

    Poster Presentations

    A. Daveluy, G. Miremont-Salamé, N. Moore, F. Haramburu in Drug Safety (2007)

previous disabled Page of 3